These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11303433)

  • 41. Broader picture surrounding new pediatric labeling for topical corticosteroid therapy.
    D'Alonzo GE
    J Am Osteopath Assoc; 1999 Jan; 99(1):15-6, 18. PubMed ID: 9972090
    [No Abstract]   [Full Text] [Related]  

  • 42. American Academy of Pediatrics. Committee on drugs. Drug testing in children: FDA regulations.
    Pediatrics; 1969 Mar; 43(3):463-5. PubMed ID: 5818481
    [No Abstract]   [Full Text] [Related]  

  • 43. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 44. Lessons from cisapride.
    CMAJ; 2001 May; 164(9):1269, 1271. PubMed ID: 11341130
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug testing in children.
    Greene J
    FDA Consum; 1978 Jun; 12(5):11-3. PubMed ID: 10308116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FDA prohibits extralabel use of two drug classes.
    J Am Vet Med Assoc; 1997 Aug; 211(3):269. PubMed ID: 9262656
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug labeling and exposure in neonates.
    Laughon MM; Avant D; Tripathi N; Hornik CP; Cohen-Wolkowiez M; Clark RH; Smith PB; Rodriguez W
    JAMA Pediatr; 2014 Feb; 168(2):130-6. PubMed ID: 24322269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The antibiotic pipeline in pediatrics.
    McCracken GH
    Adv Exp Med Biol; 2009; 634():147-51. PubMed ID: 19280856
    [No Abstract]   [Full Text] [Related]  

  • 49. Labeling for children--an unresolved problem.
    Lewis BP
    Am Pharm; 1982 Jun; NS22(6):48-51. PubMed ID: 7102552
    [No Abstract]   [Full Text] [Related]  

  • 50. Stimulation programs for pediatric drug research--do children really benefit?
    Boots I; Sukhai RN; Klein RH; Holl RA; Wit JM; Cohen AF; Burggraaf J
    Eur J Pediatr; 2007 Aug; 166(8):849-55. PubMed ID: 17225950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EU law mandates drug testing in children.
    Sinha G
    J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609
    [No Abstract]   [Full Text] [Related]  

  • 52. Pediatric Medication Errors.
    Beal JA
    MCN Am J Matern Child Nurs; 2017; 42(2):116. PubMed ID: 28234649
    [No Abstract]   [Full Text] [Related]  

  • 53. Pediatric priorities: legislative and regulatory initiatives to expand research on the use of medicines in pediatric patients.
    Labson MS
    J Health Care Law Policy; 2002; 6(1):34-72. PubMed ID: 15017951
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of US Food and Drug Administration-Approved Pediatric Labeling on Dispensing of Extended-Release Oxycodone in the Outpatient Retail Setting.
    Xu J; Gill R; Cruz M; Staffa J; Lurie P
    JAMA Pediatr; 2016 Nov; 170(11):1103-1104. PubMed ID: 27612007
    [No Abstract]   [Full Text] [Related]  

  • 55. Improving drug safety monitoring.
    Karande S; Gogtay NJ; Kshirsagar NA
    Indian Pediatr; 2003 Dec; 40(12):1167-75. PubMed ID: 14722367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bolstering the FDA's drug-safety authority.
    Schultz WB
    N Engl J Med; 2007 Nov; 357(22):2217-9. PubMed ID: 18046024
    [No Abstract]   [Full Text] [Related]  

  • 57. Package inserts for antituberculosis drugs and tuberculins.
    Snider DE; Farer LS
    Am Rev Respir Dis; 1985 Jun; 131(6):809-10. PubMed ID: 3839116
    [No Abstract]   [Full Text] [Related]  

  • 58. Dual regulatory pharmaceutical labeling schemes; the role of the Federal Preemption Doctrine.
    Fern FH; Bartell L
    Health Matrix; 1987; 5(3):17-23. PubMed ID: 10285381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Revision in pediatric immunization schedules and policy updates.
    Selekman J
    Pediatr Nurs; 1996; 22(5):424-6. PubMed ID: 9087074
    [No Abstract]   [Full Text] [Related]  

  • 60. An interview with FDA commissioner Hayes.
    Small WE
    Am Pharm; 1981 Oct; NS21(10):27-36. PubMed ID: 6803557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.